Met Life Investment Management, LLC Albireo Pharma, Inc. Transaction History

Met Life Investment Management, LLC

$14.7 Billion
Q1 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$18.01 - $23.78 $177,650 - $234,565	9,864 New	9,864 $213,000
Q3 2022 Jun 14, 2023	BUY	$16.32 - $26.37 $160,980 - $260,113	9,864 New	9,864 $190,000
Q2 2022 Jun 20, 2023	BUY	$18.54 - $37.29 $182,878 - $367,828	9,864 New	9,864 $195,000
Q1 2022 May 10, 2024	BUY	$23.94 - $33.74 $236,144 - $332,811	9,864 New	9,864 $294,000
Q1 2022 Jun 20, 2023	BUY	$23.94 - $33.74 $236,144 - $332,811	9,864 New	9,864 $294,000

Q1 2022 Mar 22, 2023	BUY	$23.94 - $33.74 $82,976 - $116,942	3,466 Added 54.17%	9,864 $294,000
Q1 2022 May 12, 2022	BUY	$23.94 - $33.74 $82,976 - $116,942	3,466 Added 54.17%	9,864 $294,000
Q4 2021 Jun 21, 2023	BUY	$21.19 - $31.29 $135,573 - $200,193	6,398 New	6,398 $149,000
Q3 2021 Jun 21, 2023	BUY	$27.36 - $35.98 $175,049 - $230,200	6,398 New	6,398 $199,000
Q2 2021 Jun 21, 2023	BUY	$28.9 - $36.87 $184,902 - $235,894	6,398 New	6,398 $225,000
Q1 2021 May 17, 2024	BUY	$32.03 - $42.85 $204,927 - $274,154	6,398 New	6,398 $225,000
Q1 2021 Jun 26, 2023	BUY	$32.03 - $42.85 $204,927 - $274,154	6,398 New	6,398 $226 Million
Q4 2020 Jun 22, 2023	BUY	$31.56 - $42.16 $201,920 - $269,739	6,398 New	6,398 $239,000
Q3 2020 Jun 26, 2023	BUY	$23.19 - $41.61 $148,369 - $266,220	6,398 New	6,398 $213,000
Q2 2020 May 24, 2024	BUY	$14.82 - $29.92 $94,818 - $191,428	6,398 New	6,398 $169 Million
Q2 2020 Jun 26, 2023	BUY	$14.82 - $29.92 $94,818 - $191,428	6,398 New	6,398 $169,000
Q2 2020 Mar 22, 2023	BUY	$14.82 - $29.92 $24,971 - $50,415	1,685 Added 35.75%	6,398 $169,000
Q2 2020 Aug 14, 2020	BUY	$14.82 - $29.92 $24,971 - $50,415	1,685 Added 35.75%	6,398 $169,000
Q1 2020 Jul 12, 2023	BUY	$11.67 - $27.23 $55,000 - $128,334	4,713 New	4,713 $77,000
Q4 2019 Jul 12, 2023	BUY	$16.92 - $28.96 $79,743 - $136,488	4,713 New	4,713 $119,000
Q3 2019 Jul 12, 2023	BUY	$20.0 - $31.88 $94,260 - $150,250	4,713 New	4,713 $94,000
Q2 2019 Jul 12, 2023	BUY	$30.67 - $37.86 $144,547 - $178,434	4,713 New	4,713 $151,000
Q1 2019 Jul 13, 2023	BUY	$22.22 - $32.21 $104,722 - $151,805	4,713 New	4,713 $151,000
Q4 2018 Jul 13, 2023	BUY	$20.9 - $32.57 $98,501 - $153,502	4,713 New	4,713 $115,000
Q4 2018 Mar 22, 2023	SELL	$20.9 - $32.57 $54,319 - $84,649	-2,599 Reduced 35.54%	4,713 $115,000
Q4 2018 Feb 14, 2019	SELL	$20.9 - $32.57 $54,319 - $84,649	-2,599 Reduced 35.54%	4,713 $116,000
Q3 2018 Jul 13, 2023	BUY	$29.29 - $36.87 $138,043 - $173,768	4,713 New	4,713 $155,000
Q3 2018 Mar 22, 2023	SELL	$29.29 - $36.87 $74,748 - $94,092	-2,552 Reduced 25.87%	7,312 $241,000
Q3 2018 Nov 14, 2018	BUY	$29.29 - $36.87 $76,124 - $95,825	2,599 Added 55.15%	7,312 $241,000
Q2 2018 Aug 15, 2018	BUY	$28.9 - $37.31 $136,205 - $175,842	4,713 New	4,713 $167,000

Others Institutions Holding ALBO

# of Institutions

Shares Held

865

Call Options Held

Put Options Held

View Full List

About ALBIREO PHARMA, INC.

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

More about ALBO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account